Senate Bill S9890

2023-2024 Legislative Session

Directs the commissioner of health to conduct a study to identify, analyze, report, and medically combat new or previously unseen opiate/opioid compounds found in overdose patients in New York state

download bill text pdf

Sponsored By

Current Bill Status - In Senate Committee Rules Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

2023-S9890 (ACTIVE) - Details

See Assembly Version of this Bill:
A7746
Current Committee:
Senate Rules
Law Section:
Health, Commissioner of

2023-S9890 (ACTIVE) - Summary

Directs the commissioner of health to conduct a study to identify, analyze, report, and medically combat new or previously unseen opiate/opioid compounds found in overdose patients in New York state for the purpose of establishing more efficient overdose medical treatment protocols.

2023-S9890 (ACTIVE) - Sponsor Memo

2023-S9890 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   9890
 
                             I N  S E N A T E
 
                              August 16, 2024
                                ___________
 
 Introduced  by  Sen. ROLISON -- read twice and ordered printed, and when
   printed to be committed to the Committee on Rules
 
 AN ACT directing the commissioner of health to conduct a study to  iden-
   tify,  analyze,  report, and medically combat new or previously unseen
   opiate/opioid compounds found in overdose patients in New  York  state
   for the purpose of establishing more efficient overdose medical treat-
   ment protocols
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. This act shall be known and may be cited as  the  "identify
 dangerous drugs act (IDDA)".
   §  2.  The opioid settlement fund advisory board, established pursuant
 to section 25.18 of the mental hygiene law, shall direct the commission-
 er of health to conduct a study of 250 random  urine  samples  collected
 anonymously  throughout  the  state of New York. Such samples shall: (i)
 represent each county in the state; (ii) be provided in accordance  with
 HIPAA  laws  and  regulations; and (iii) be identified by emergency room
 hospital physicians as having been generated from patients who,  at  the
 time  of  collection, were experiencing moderate to severe medical symp-
 toms diagnosed as being directly related to an overdose associated  from
 the use of an illicit unidentified opioid/opiate substance and/or combi-
 nation of substances. Such urine samples shall:
   (a)  only  be  collected  from patients diagnosed by an emergency room
 physician as experiencing moderate  or  severe  overdose  symptoms  most
 likely related to opiate/opioid patient use;
   (b)  be collected by designated trained medical staff, including nurs-
 es, physicians, and physician assistants;
   (c) be collected in tandem with the written and verbal consent of  the
 patient  and follow all designated HIPAA laws and regulations, including
 but not limited to identifying samples only by number on a form supplied
 to the hospital by the department of health. Such written consent  shall
 be  knowing  and  willful. The patient shall be verbally read conditions
 and forms by medical staff identified above and shall  sign  a  document
 supplied  by  the department of health. Patients shall verbalize consent
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.